Polyneuron Pharmaceuticals

Immune Disorders


HBM contact: Dr Emil Bujak

Company status: private

Polyneuron has a unique approach in using antigen-specific polymers to target and eliminate the pathological antibodies causing serious autoimmune diseases with a high unmet medical need.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171